XBI vs XLV

Both XBI and XLV are ETFs. XBI has a lower 5-year return than XLV (6.62% vs 8.06%). XBI has a higher expense ratio than XLV (0.35% vs 0.13%). Below is the comparison between XBI and XLV.

XBI XLV
Segment Equity: U.S. Biotech Equity: U.S. Health Care
Issuer State Street Global Advisors State Street Global Advisors
Net Assets $5.05B $25.75B
Expense Ratio 0.35% 0.13%
Management Style passive (index-based) passive (index-based)
Dividend Yield 0.00% 2.25%
Underlying Index S&P Biotechnology Select Industry Index S&P Health Care Select Sector Index
YTD Return 7.95% -0.91%
1-Year Return 24.51% 16.98%
3-Year Return 13.67% 11.88%
5-Year Return 6.62% 8.06%
10-Year Return 18.91% 14.86%

XBI description

The Fund seeks to replicate as closely as possible the performance of an index derived from the biotechnology segment of a U.S. total market composite index. The Fund uses a passive management strategy designed to track the total return performance of the S&P Biotechnology Select Industry Index.

XBI performance & returns

YTD Return 7.95%
1-Month Return 21.52%
3-Month Return 5.75%
1-Year Return 24.51%
3-Year Return 13.67%
5-Year Return 6.62%
10-Year Return 18.91%
XBI expense ratio is 0.35%.

XBI holdings

Top 10 Holdings (23.22% of Total Assets)

Name Symbol % Assets
Regeneron Pharmaceuticals Inc REGN 2.77%
Moderna Inc MRNA 2.65%
Gilead Sciences Inc GILD 2.43%
Vertex Pharmaceuticals Inc VRTX 2.32%
Biogen Inc BIIB 2.28%
United Therapeutics Corp UTHR 2.26%
Biomarin Pharmaceutical Inc BMRN 2.25%
Seattle Genetics Inc SGEN 2.16%
Exelixis Inc EXEL 2.06%
ACADIA Pharmaceuticals Inc ACAD 2.04%

Other relevant XBI comparisons

You may also want to check out the following XBI comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

XLV description

The Fund seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index. Under normal market conditions, the fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index.

XLV performance & returns

YTD Return -0.91%
1-Month Return 3.93%
3-Month Return -2.88%
1-Year Return 16.98%
3-Year Return 11.88%
5-Year Return 8.06%
10-Year Return 14.86%
XLV expense ratio is 0.13%.

XLV holdings

Top 10 Holdings (51.49% of Total Assets)

Name Symbol % Assets
Johnson & Johnson JNJ 10.45%
UnitedHealth Group Inc UNH 7.16%
Merck & Co Inc MRK 5.93%
Pfizer Inc PFE 5.47%
Abbott Laboratories ABT 4.22%
Bristol-Myers Squibb Company BMY 3.96%
Medtronic PLC MDT 3.66%
Amgen Inc AMGN 3.65%
Eli Lilly and Co LLY 3.55%
Thermo Fisher Scientific Inc TMO 3.44%

Other relevant XLV comparisons

You may also want to check out the following XLV comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
Follow Us